Solid-basaloid variant of adenoid cystic carcinoma of the breast with near complete response to neoadjuvant chemotherapy Journal Article

   

Authors:	Grabenstetter, A.; Brogi, E.; Zhang, H.; Razavi, P.; Reis-Filho, J. S.; VanZee, K. J.; Norton, L.; Wen, H. Y.
Article Title:	Solid-basaloid variant of adenoid cystic carcinoma of the breast with near complete response to neoadjuvant chemotherapy
Abstract:	Breast adenoid cystic carcinoma (AdCC) is a rare subtype of triple negative breast cancer. Two morphologic variants are described, namely classic AdCC (C-AdCC) and solid basaloid (SB-AdCC). Recent studies have shown that the SB-AdCC variant has significantly worse prognosis than C-AdCC. Due to the rarity of SB-AdCC, no standard recommendations are available for its management. Data on the use and benefit of chemotherapy in patients with SB-AdCC are sparse and the response to neoadjuvant chemotherapy has not been reported. We present the clinical and pathologic findings of a patient with SB-AdCC treated with neoadjuvant chemotherapy who achieved a remarkable pathologic response. © 2022, The Author(s).
Journal Title:	npj Breast Cancer
Volume:	8
ISSN:	2374-4677
Publisher:	Nature Publishing Group
Date Published:	2022-08-11
Start Page:	93
Language:	English
DOI:	10.1038/s41523-022-00469-z
PROVIDER:	scopus
PMCID:	PMC9372162
PUBMED:	35953528
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85135848449&doi=10.1038%2fs41523-022-00469-z&partnerID=40&md5=48e4c50857b6786260a188437602eff6
Notes:	Article -- Export Date: 1 September 2022 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/197165